EUCRU

Eucrates Biomedical Acqu... (EUCRU)

Eucrates Biomedical Acquisition Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:EUCRU

일자	시간	출처	헤드라인	심볼	기업
2023/04/27	05:53	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2023/04/12	06:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2023/04/04	05:19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2023/03/30	05:41	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2023/02/17	06:14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2023/02/10	23:44	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2022/11/15	07:37	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2022/11/09	06:29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2022/11/01	05:20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2022/10/06	06:21	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2022/05/17	05:50	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2022/04/11	19:04	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2022/02/15	04:43	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2022/02/09	07:17	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2022/01/27	06:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2021/12/21	06:34	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2021/11/23	06:33	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2021/11/16	20:05	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2021/08/17	04:27	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2021/07/17	05:07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2021/07/16	06:29	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2021/06/22	05:23	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2021/05/17	20:33	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2021/04/01	05:03	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2021/02/13	06:04	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2021/02/08	20:02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2020/12/15	07:28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2020/12/15	07:22	PR Newswire (US)	Eucrates Biomedical Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Redeemable Warrants	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2020/12/08	07:26	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
2020/10/28	05:17	PR Newswire (US)	Eucrates Biomedical Acquisition Corp. Announces Closing Of $100 Million Initial Public Offering	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation